Overdose Pharmacology and Toxicology Expert

Specialties & Experience of this Expert Witness

Additional Information

Dr. Atkinson is a Clinical Pharmacy Practitioner in Pain Management specializing in high-risk chronic pain medication management for more than 12 years. He has extensive experience in providing comprehensive drug therapy management with controlled substances, polypharmacy, and polysubstance use. He ran a suboxone clinic for patients with comorbid opioid use disorder and high-risk chronic pain for years and served as director of a pharmacy pain residency training program. Dr. Atkinson is a frequent and experienced national speaker at pain conferences on pain pharmacology and toxicology topics. Dr. Atkinson is a national subject matter expert in opioid and controlled substance prescribing and management including regulatory requirements for standard risk mitigation activities. He has served for many years as a public policy expert on opioids for federal agencies, guideline workgroups, and the section editor on opioids and substance use disorders for the journal of pain research. Dr. Atkinson has consulted for insurers on creation of opioid and controlled substance metrics, development of risk scores, and their application to practice. Dr. Atkinson is well published in both peer reviewed journals and textbooks on pain pharmacology and toxicology topics and frequently develops continuing education and speaking activities on these topics. Dr. Atkinson's full profile and experience is available via his CV or LinkedIn profile: https://www.linkedin.com/in/tim-atkinson-95b520b0/ Areas of expertise: Opioid overdose/poisoning or suicide, gabapentin/pregabalin overdose, NSAID toxicity, CNS depressants, polypharmacy, polysubstance misuse/abuse, opioid management, liver dysfunction, kidney dysfunction, elderly controlled substance prescribing, opioid forced taper/discontinuation, opioid safety, controlled substance prescribing, opioid risk mitigation activities, urine drug toxicology, serum drug testing, prescription drug monitoring program (PDMP).